Earnings Feed
Start Free
Home/Filings/4/0000914190-11-000278
4//SEC Filing

KASH PETER M 4

Accession 0000914190-11-000278

CIK 0001133869other
View on SEC.govCompany Profile

Filed

May 11, 8:00 PM ET

Accepted

May 12, 5:58 PM ET

Size

19.8 KB

Accession

0000914190-11-000278

Insider Transaction Report

Form 4
Period: 2011-05-10
Nile Therapeutics, Inc.NLTX
KASH PETER M
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2011-05-10+80,000→ 80,000 total
    Exercise: $0.73From: 2012-05-10Exp: 2021-05-10→ Common Stock (80,000 underlying)
Holdings

  • Common Stock

    1,596,208

  • Common Stock

    (indirect: By Foundation)
    165,530

  • Stock Option (Right to Buy)

    Exercise: $4.50Exp: 2018-01-25→ Common Stock (60,000 underlying)
    60,000

  • Stock Option (Right to Buy)

    Exercise: $1.77From: 2010-07-21Exp: 2019-07-21→ Common Stock (80,000 underlying)
    80,000

  • Stock Option (Right to Buy)

    Exercise: $0.37From: 2011-07-26Exp: 2020-07-26→ Common Stock (80,000 underlying)
    80,000

  • Warrant (Right to Buy)

    Exercise: $2.28From: 2009-07-07Exp: 2014-07-07→ Common Stock (49,407 underlying)
    49,407

  • Warrant (Right to Buy)

    Exercise: $2.71From: 2007-09-17Exp: 2011-09-17→ Common Stock (1,052 underlying)
    1,052

  • Common Stock

    (indirect: By Spouse)
    496,589

  • Stock Option (Right to Buy)

    Exercise: $0.93From: 2010-01-01Exp: 2018-12-22→ Common Stock (35,000 underlying)
    35,000

  • Warrant (Right to Buy)

    Exercise: $1.25From: 2009-07-07Exp: 2014-07-07→ Common Stock (24,704 underlying)
    24,704

  • Warrant (Right to Buy)

    Exercise: $1.71From: 2009-07-07Exp: 2014-07-07→ Common Stock (24,703 underlying)
    24,703

  • Warrant (Right to Buy)

    Exercise: $1.38From: 2009-07-15Exp: 2019-07-15→ Common Stock (125,000 underlying)
    125,000
Footnotes (2)
  • [F1]Held by the Reporting Person's spouse as custodian for the benefit of their minor children under the Uniform Gift to Minors Act. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of these shares for purposes of Section 16 or any other purpose.
  • [F2]Fully exercisable.

Documents

1 file

Issuer

Nile Therapeutics, Inc.

CIK 0001133869

→
Entity typeother

Related Parties

1
  • filerCIK 0001253023

Filing Metadata

Form type
4
Filed
May 11, 8:00 PM ET
Accepted
May 12, 5:58 PM ET
Size
19.8 KB
View on SEC.gov